Health Condition 1: C96Z- Other specified malignant neoplasms of lymphoid, hematopoietic and related tissue
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Control Intervention1: TREATMENT OF NEWLY DIAGNOSED CANCER PATIENT: PRE CHEMOTHERAPY AND POST 3 MONTH CHEMOTHERAPY
Control Intervention2: Nil: Nil
Sponsors
DANIYAL
Eligibility
Inclusion criteria
Inclusion criteria: CHILDREN 1-12 YEARS WITH NEWLY DIAGNOSED MALIGNANCY AND REQUIRING CHEMOTHERAPY
Exclusion criteria
Exclusion criteria: PREVIOUS THERAPY TAKEN FOR MALIGNANCY RELAPSE OR RECURRENT MALIGNANCY
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PROPORTION OF TREATMENT NAIIVE CHILDREN WITH NEWLY DIAGNOSED MALIGNANCY WITH ATLEAST ONE MICRONUTRIENT DEFICIENCY AT BASELINETimepoint: AT PRESENTATION | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.PROPORTION OF TREATMENT NAIIVE CHILDREN WITH NEWLY DIAGNOISED MALIGNANCY WITH ATLEAST ONE MICRONUTIENT DEFICIENCY AT 3 MONTHS POST CHEMOTHERAPY INITIATION 2.ASSOCIATION BETWEEN VARIOUS MICRONUTRIENT DEFICIENCIES PRE AND POST 3 MONTH OF CHEMOYTHERAPYTimepoint: 3 MONTH | — |
Countries
India
Contacts
Public ContactPUNEET KAUR SAHI
MAULANA AZAD MEDICAL COLLEGE
Outcome results
None listed